Improved real-life adherence of 6-monthly denosumab injections due to positive feedback based on rapid 6-month BMD increase and good safety profile.
about
Update on denosumab in the management of postmenopausal osteoporosis: patient preference and adherenceOsteoporosis in men: epidemiology and treatment with denosumab.Persistence with denosumab therapy in women affected by osteoporosis with fragility fractures: a multicenter observational real practice study in Italy.[Male osteoporosis].Frequency of discontinuation of injectable osteoporosis therapies in US patients over 2 years.Medication-taking behaviour in Bulgarian women with postmenopausal osteoporosis treated with denosumab or monthly oral bisphosphonates.
P2860
Improved real-life adherence of 6-monthly denosumab injections due to positive feedback based on rapid 6-month BMD increase and good safety profile.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年学术文章
@wuu
2013年学术文章
@zh
2013年学术文章
@zh-cn
2013年学术文章
@zh-hans
2013年学术文章
@zh-my
2013年学术文章
@zh-sg
2013年學術文章
@yue
2013年學術文章
@zh-hant
name
Improved real-life adherence o ...... rease and good safety profile.
@en
Improved real-life adherence o ...... rease and good safety profile.
@nl
type
label
Improved real-life adherence o ...... rease and good safety profile.
@en
Improved real-life adherence o ...... rease and good safety profile.
@nl
prefLabel
Improved real-life adherence o ...... rease and good safety profile.
@en
Improved real-life adherence o ...... rease and good safety profile.
@nl
P2860
P1476
Improved real-life adherence o ...... rease and good safety profile.
@en
P2093
P Farahmand
P2860
P2888
P304
P356
10.1007/S00296-012-2663-2
P577
2013-01-19T00:00:00Z